Loading…
DIA Europe 2019 has ended
Back To Schedule
Wednesday, February 6 • 12:00 - 13:15
#S0202: How Can the EU Regulatory Network Support Innovation?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session

The session will review the support mechanism of the medicines regulators and HTA bodies for the innovators to enhance innovation. It also will review the new Horizon 2020 STARS program aiming to improve the regulatory knowledge of academic groups.

Chair

Esa Henrik Heinonen, DrMed

Speaker

EMA’s Perspective
Anthony Humphreys, MPharm

What is The EU-Innovation Network?
Esa Henrik Heinonen, DrMed

STARS Project – Approaching Academic Centers
Julia Stingl, DrMed

IMI Projects – Role of a Regulator
Isabelle Bekeredjian-Ding, MD

EU Cooperation on HTA - Today and Tomorrow
Ana-Eva Ampelas, LLM


Speakers
AA

Ana-Eva Ampelas

Head of Unit, Medical products: Quality, Safety, Innovation, European Commission
Anna-Eva Ampelas is Head of Unit for Medical Products: quality, safety, innovation in Unit B4 in DG SANTE, European Commission. In this capacity, she manages files on medicinal products (falsified medicines, clinical trials, shortages, GMP etc); Health Technology Assessments (HTA... Read More →
avatar for Isabelle Bekeredjian-Ding

Isabelle Bekeredjian-Ding

Head of Division of Microbiology, Paul-Ehrlich-Institut (PEI)
Isabelle Bekeredjian-Ding is Head of the Microbiology Division at Paul-Ehrlich-Institut. She is a Medical Microbiologist and Immunologist and Associate Professor at the University of Bonn. She received Medical School training at the University of Heidelberg, Padova (Italy) and Mt... Read More →
avatar for Esa Heinonen

Esa Heinonen

Director, Assessment of Medicinal Products, Finnish Medicines Agency (Fimea)
Dr. Heinonen is a medical doctor with over twenty years of management experience in pharmaceutical R&D (senior VP)especially in the fields of neurology and oncology. He is Adjunct Professor of Drug Development (University of Turku, Finland). He has also over 10 years management experience... Read More →
avatar for Julia Stingl

Julia Stingl

Vice President and Head of Research, Bfarm
Julia C Stingl (formerly Kirchheiner) M.D. is professor of translational pharmacology at the University Bonn Medical Faculty and head of the research division of the Federal Institute of Drugs and Medical Devices. Since 2014 she is Vice President of the institute. Her research mostly... Read More →
avatar for Anthony Humphreys

Anthony Humphreys

Head of Scientific Committees Regulatory Science Strategy, European Medicines Agency (EMA)
He is the Head of Scientific Committees Regulatory Science Strategy Division (SciRS). He is responsible for providing leadership in the Agency in the areas of Scientific Committees Coordination and Regulatory Science Strategy in support of delivering the EMRN 2020 Strategy. He chairs... Read More →

Wednesday February 6, 2019 12:00 - 13:15 CET
F2 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  02 Evolution of Science and Policy, Session
  • Featured Topics Translational Medicine
  • Tags Session